PhaseBio Pharmaceuticals, Inc. (PHAS)
Working Capital Ratio
-59.17%
Quarterly · Period ending:
PHAS Working Capital Ratio
Latest reported34.52%period ending
Latest reported34.52%period ending
PHAS FY Working Capital Ratio (73.84% → 34.52%)
Annual working capital ratio
High-resolution chart · PNG
PHAS working capital ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 34.5243% | |
| 50.0209% | |
| 85.2717% | |
| 92.1064% | |
| -27.2998% | |
| 73.8402% |